Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA
Biotech
Lilly M&A streak rolls on with purchase of DNA delivery biotech
Engage is developing novel non-viral DNA delivery systems that aim to overcome traditional limitations associated with the modality.
Eric Sagonowsky
May 20, 2026 10:48am
New Flagship biotech circles in on new DNA drug class
Apr 21, 2026 6:30am
Valerio ends all clinical activity, shuts down US site
Feb 4, 2025 12:09pm
Merck snaps up preclinical DNA biotech for $1.3B biobucks
Oct 23, 2024 7:05am
Eli Lilly opens $700M nucleic acid R&D center in Boston Seaport
Aug 13, 2024 9:32am
Rome's 'dark genome' drug reduces autoimmune markers in mice
Nov 17, 2023 1:03pm
